Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Williams

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Diabetes Care|June 13, 2020
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsEle Ferrannini, Ashwin C Murthy, Yong-Ho Lee, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Journal of the American Heart Association|July 23, 2020
Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart DiseaseJoseph Yang, Edward N Brody, Ashwin C Murthy, et al.
Diabetes Care|January 29, 2020
Coronary Artery Disease and Type 2 Diabetes: A Proteomic StudyGiulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
American Journal of Preventive Cardiology|June 15, 2026
Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trialRosalynn Gill, Meredith A Carpenter, Amy Holstein, et al.
The Science of the Total Environment|September 1, 2021
Modeling nitrous oxide mitigation potential of enhanced efficiency nitrogen fertilizers from agricultural systemsRam B Gurung, Stephen M Ogle, F Jay Breidt, et al.
Plos One|October 12, 2012
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance toolRachel M Ostroff, Michael R Mehan, Alex Stewart, et al.
Nature Medicine|November 10, 2022
Proteomic signatures for identification of impaired glucose toleranceJulia Carrasco-Zanini, Maik Pietzner, Joni V Lindbohm, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Diabetes Care|June 13, 2020
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsEle Ferrannini, Ashwin C Murthy, Yong-Ho Lee, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Journal of the American Heart Association|July 23, 2020
Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart DiseaseJoseph Yang, Edward N Brody, Ashwin C Murthy, et al.
Diabetes Care|January 29, 2020
Coronary Artery Disease and Type 2 Diabetes: A Proteomic StudyGiulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.
American Journal of Preventive Cardiology|June 15, 2026
Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trialRosalynn Gill, Meredith A Carpenter, Amy Holstein, et al.
The Science of the Total Environment|September 1, 2021
Modeling nitrous oxide mitigation potential of enhanced efficiency nitrogen fertilizers from agricultural systemsRam B Gurung, Stephen M Ogle, F Jay Breidt, et al.
Plos One|October 12, 2012
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance toolRachel M Ostroff, Michael R Mehan, Alex Stewart, et al.
Nature Medicine|November 10, 2022
Proteomic signatures for identification of impaired glucose toleranceJulia Carrasco-Zanini, Maik Pietzner, Joni V Lindbohm, et al.
Pageof 4